| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alzheimer Disease | 62 | 2024 | 514 | 10.680 |
Why?
|
| Amyloid beta-Peptides | 26 | 2024 | 213 | 3.260 |
Why?
|
| Oxidative Stress | 34 | 2020 | 458 | 2.810 |
Why?
|
| tau Proteins | 20 | 2024 | 76 | 2.680 |
Why?
|
| Genome | 12 | 2024 | 391 | 2.370 |
Why?
|
| Biological Evolution | 15 | 2023 | 970 | 2.220 |
Why?
|
| Lemur | 6 | 2024 | 16 | 2.130 |
Why?
|
| Brain | 30 | 2024 | 2303 | 2.020 |
Why?
|
| Evolution, Molecular | 19 | 2021 | 854 | 2.010 |
Why?
|
| Neurodegenerative Diseases | 8 | 2024 | 51 | 1.930 |
Why?
|
| Primates | 6 | 2020 | 155 | 1.880 |
Why?
|
| Genome, Human | 13 | 2021 | 791 | 1.830 |
Why?
|
| Amyloid | 5 | 2017 | 95 | 1.760 |
Why?
|
| Aging | 11 | 2016 | 726 | 1.630 |
Why?
|
| Gene Dosage | 10 | 2012 | 210 | 1.540 |
Why?
|
| Neuroprotective Agents | 4 | 2020 | 100 | 1.480 |
Why?
|
| Genetic Variation | 18 | 2024 | 1380 | 1.450 |
Why?
|
| Pan troglodytes | 8 | 2014 | 203 | 1.360 |
Why?
|
| Nervous System Diseases | 2 | 2022 | 163 | 1.350 |
Why?
|
| Genetics, Population | 8 | 2021 | 407 | 1.310 |
Why?
|
| Genomics | 7 | 2021 | 776 | 1.220 |
Why?
|
| Animals | 69 | 2024 | 27512 | 1.160 |
Why?
|
| Humans | 126 | 2024 | 89785 | 1.060 |
Why?
|
| Extinction, Biological | 5 | 2021 | 89 | 1.050 |
Why?
|
| Mitochondria | 7 | 2023 | 555 | 1.040 |
Why?
|
| Paleontology | 3 | 2015 | 83 | 1.040 |
Why?
|
| Adaptation, Physiological | 7 | 2023 | 318 | 1.030 |
Why?
|
| Antioxidants | 6 | 2019 | 226 | 1.020 |
Why?
|
| Dementia | 3 | 2018 | 203 | 1.010 |
Why?
|
| Hominidae | 4 | 2017 | 97 | 1.000 |
Why?
|
| Plaque, Amyloid | 12 | 2024 | 59 | 1.000 |
Why?
|
| Selection, Genetic | 6 | 2021 | 515 | 0.990 |
Why?
|
| Metals | 2 | 2020 | 93 | 0.930 |
Why?
|
| Body Size | 2 | 2014 | 93 | 0.920 |
Why?
|
| Oxidation-Reduction | 12 | 2020 | 388 | 0.920 |
Why?
|
| Neurofibrillary Tangles | 14 | 2022 | 46 | 0.890 |
Why?
|
| Iron | 9 | 2024 | 168 | 0.860 |
Why?
|
| Phylogeny | 12 | 2021 | 1196 | 0.790 |
Why?
|
| DNA | 7 | 2015 | 1311 | 0.790 |
Why?
|
| Neurons | 18 | 2012 | 1589 | 0.770 |
Why?
|
| Vaccines | 1 | 2023 | 84 | 0.760 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2024 | 312 | 0.750 |
Why?
|
| Anthropology, Physical | 1 | 2021 | 14 | 0.750 |
Why?
|
| Tauopathies | 2 | 2019 | 14 | 0.740 |
Why?
|
| Strepsirhini | 2 | 2017 | 7 | 0.720 |
Why?
|
| Urban Renewal | 1 | 2020 | 2 | 0.710 |
Why?
|
| Cell- and Tissue-Based Therapy | 1 | 2020 | 51 | 0.700 |
Why?
|
| Clinical Trials as Topic | 3 | 2023 | 1134 | 0.700 |
Why?
|
| Genetic Markers | 3 | 2017 | 476 | 0.690 |
Why?
|
| Neurotransmitter Agents | 1 | 2020 | 108 | 0.680 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2019 | 102 | 0.670 |
Why?
|
| Apolipoproteins E | 1 | 2020 | 130 | 0.670 |
Why?
|
| Lewy Body Disease | 5 | 2023 | 10 | 0.670 |
Why?
|
| Aquaporin 3 | 1 | 2019 | 1 | 0.650 |
Why?
|
| Erythrocyte Membrane | 1 | 2019 | 61 | 0.640 |
Why?
|
| Immunologic Factors | 1 | 2020 | 171 | 0.640 |
Why?
|
| Glycerol | 1 | 2019 | 35 | 0.630 |
Why?
|
| Peptide Fragments | 3 | 2017 | 462 | 0.630 |
Why?
|
| Prion Diseases | 4 | 2010 | 35 | 0.610 |
Why?
|
| Species Specificity | 11 | 2020 | 685 | 0.600 |
Why?
|
| Sequence Analysis, DNA | 10 | 2017 | 869 | 0.590 |
Why?
|
| Genetic Therapy | 1 | 2020 | 372 | 0.590 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2020 | 346 | 0.580 |
Why?
|
| Color Vision | 3 | 2017 | 15 | 0.580 |
Why?
|
| Echolocation | 1 | 2017 | 6 | 0.580 |
Why?
|
| Pattern Recognition, Physiological | 1 | 2017 | 7 | 0.580 |
Why?
|
| Body Fluids | 1 | 2017 | 34 | 0.570 |
Why?
|
| Plant Extracts | 1 | 2019 | 245 | 0.570 |
Why?
|
| Boxing | 1 | 2017 | 1 | 0.570 |
Why?
|
| Microsatellite Repeats | 1 | 2017 | 148 | 0.560 |
Why?
|
| Genotyping Techniques | 1 | 2017 | 69 | 0.560 |
Why?
|
| Sodium Chloride | 1 | 2017 | 88 | 0.560 |
Why?
|
| Neurology | 1 | 2018 | 75 | 0.560 |
Why?
|
| Behavior, Animal | 1 | 2020 | 380 | 0.560 |
Why?
|
| alpha-Synuclein | 4 | 2024 | 20 | 0.560 |
Why?
|
| Thermodynamics | 1 | 2017 | 314 | 0.550 |
Why?
|
| RNA | 3 | 2012 | 583 | 0.550 |
Why?
|
| Rod Opsins | 4 | 2017 | 9 | 0.550 |
Why?
|
| Ferrosoferric Oxide | 1 | 2016 | 19 | 0.540 |
Why?
|
| DNA, Mitochondrial | 4 | 2017 | 189 | 0.530 |
Why?
|
| Hippocampus | 9 | 2014 | 449 | 0.520 |
Why?
|
| Base Sequence | 8 | 2021 | 2329 | 0.500 |
Why?
|
| Lipid Peroxidation | 3 | 2011 | 45 | 0.500 |
Why?
|
| Madagascar | 7 | 2024 | 29 | 0.490 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2017 | 490 | 0.470 |
Why?
|
| Brain Injuries | 1 | 2017 | 166 | 0.470 |
Why?
|
| Apolipoprotein E4 | 2 | 2013 | 27 | 0.470 |
Why?
|
| Growth Disorders | 1 | 2014 | 63 | 0.460 |
Why?
|
| Pathology | 2 | 2011 | 32 | 0.450 |
Why?
|
| Cell Nucleus | 2 | 2021 | 602 | 0.440 |
Why?
|
| Drug Design | 2 | 2024 | 123 | 0.440 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 47 | 0.440 |
Why?
|
| Aldehydes | 2 | 2011 | 20 | 0.440 |
Why?
|
| Darkness | 2 | 2017 | 49 | 0.430 |
Why?
|
| Erythrocytes | 1 | 2013 | 254 | 0.420 |
Why?
|
| Dementia, Vascular | 1 | 2012 | 6 | 0.400 |
Why?
|
| Guanosine | 4 | 2009 | 30 | 0.400 |
Why?
|
| Feeding Behavior | 1 | 2015 | 328 | 0.400 |
Why?
|
| Histocytochemistry | 1 | 2012 | 130 | 0.390 |
Why?
|
| Models, Neurological | 2 | 2012 | 411 | 0.370 |
Why?
|
| Aged | 28 | 2023 | 19212 | 0.370 |
Why?
|
| DNA Damage | 1 | 2012 | 373 | 0.360 |
Why?
|
| Nerve Degeneration | 4 | 2009 | 83 | 0.360 |
Why?
|
| DNA Repair | 1 | 2012 | 363 | 0.360 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3024 | 0.360 |
Why?
|
| Sequence Analysis, RNA | 1 | 2011 | 241 | 0.340 |
Why?
|
| Retinal Rod Photoreceptor Cells | 1 | 2009 | 9 | 0.340 |
Why?
|
| Diet | 5 | 2023 | 444 | 0.340 |
Why?
|
| Parkinson Disease | 5 | 2011 | 150 | 0.330 |
Why?
|
| Forests | 4 | 2021 | 23 | 0.330 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 383 | 0.330 |
Why?
|
| Immunohistochemistry | 14 | 2019 | 1799 | 0.320 |
Why?
|
| Models, Genetic | 5 | 2017 | 948 | 0.320 |
Why?
|
| Feces | 1 | 2010 | 332 | 0.320 |
Why?
|
| Body Height | 1 | 2009 | 100 | 0.310 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 29 | 0.300 |
Why?
|
| Disaster Planning | 2 | 2008 | 24 | 0.300 |
Why?
|
| alpha-Amylases | 1 | 2007 | 2 | 0.300 |
Why?
|
| Aged, 80 and over | 19 | 2019 | 6778 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2017 | 2414 | 0.290 |
Why?
|
| Fossils | 3 | 2015 | 347 | 0.280 |
Why?
|
| Biomarkers | 5 | 2018 | 1773 | 0.280 |
Why?
|
| Chromosomes, Human, Y | 1 | 2007 | 24 | 0.280 |
Why?
|
| Phenotype | 7 | 2015 | 2450 | 0.280 |
Why?
|
| Circadian Rhythm | 1 | 2009 | 303 | 0.280 |
Why?
|
| Transcriptome | 1 | 2011 | 660 | 0.270 |
Why?
|
| Sequence Alignment | 4 | 2015 | 354 | 0.270 |
Why?
|
| Independent Living | 1 | 2016 | 21 | 0.270 |
Why?
|
| Neanderthals | 2 | 2017 | 16 | 0.260 |
Why?
|
| PAX9 Transcription Factor | 1 | 2005 | 2 | 0.260 |
Why?
|
| MSX1 Transcription Factor | 1 | 2005 | 3 | 0.260 |
Why?
|
| Copper | 2 | 2004 | 78 | 0.260 |
Why?
|
| Color Perception | 1 | 2007 | 118 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 5 | 2012 | 511 | 0.260 |
Why?
|
| Gene Deletion | 1 | 2007 | 341 | 0.250 |
Why?
|
| Trust | 1 | 2016 | 97 | 0.250 |
Why?
|
| Substance Abuse, Intravenous | 1 | 2016 | 59 | 0.250 |
Why?
|
| Social Environment | 1 | 2016 | 187 | 0.250 |
Why?
|
| Endangered Species | 2 | 2017 | 24 | 0.240 |
Why?
|
| Rhodanine | 1 | 2024 | 1 | 0.240 |
Why?
|
| Regulatory Elements, Transcriptional | 2 | 2017 | 46 | 0.240 |
Why?
|
| Thiourea | 1 | 2024 | 9 | 0.240 |
Why?
|
| Urea | 1 | 2024 | 59 | 0.240 |
Why?
|
| Community Health Services | 1 | 2016 | 82 | 0.240 |
Why?
|
| Influenza, Human | 2 | 2008 | 340 | 0.240 |
Why?
|
| Fluorescent Dyes | 2 | 2024 | 245 | 0.240 |
Why?
|
| Social Support | 1 | 2016 | 216 | 0.240 |
Why?
|
| Mitochondrial Membranes | 1 | 2023 | 15 | 0.220 |
Why?
|
| Microtubules | 2 | 2004 | 123 | 0.220 |
Why?
|
| Olfactory Mucosa | 1 | 2003 | 33 | 0.220 |
Why?
|
| beta-Defensins | 2 | 2013 | 12 | 0.210 |
Why?
|
| Gene Editing | 1 | 2023 | 50 | 0.210 |
Why?
|
| Reactive Oxygen Species | 5 | 2012 | 490 | 0.210 |
Why?
|
| History, 21st Century | 3 | 2012 | 184 | 0.200 |
Why?
|
| History, 20th Century | 3 | 2012 | 314 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 6 | 2013 | 693 | 0.200 |
Why?
|
| Temporal Lobe | 1 | 2002 | 176 | 0.190 |
Why?
|
| Geography | 2 | 2013 | 227 | 0.190 |
Why?
|
| Male | 26 | 2019 | 42582 | 0.190 |
Why?
|
| Middle Aged | 22 | 2019 | 26080 | 0.190 |
Why?
|
| Poverty | 2 | 2016 | 183 | 0.190 |
Why?
|
| Cebus | 1 | 2021 | 19 | 0.180 |
Why?
|
| Publications | 1 | 2021 | 27 | 0.180 |
Why?
|
| Brain Chemistry | 5 | 2008 | 122 | 0.180 |
Why?
|
| Membrane Proteins | 3 | 2017 | 1227 | 0.180 |
Why?
|
| Macaca mulatta | 3 | 2014 | 466 | 0.180 |
Why?
|
| Longevity | 1 | 2021 | 58 | 0.180 |
Why?
|
| Disease Outbreaks | 2 | 2008 | 156 | 0.180 |
Why?
|
| Metagenomics | 1 | 2021 | 92 | 0.180 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 85 | 0.180 |
Why?
|
| Liver | 3 | 2015 | 1211 | 0.170 |
Why?
|
| Ginkgo biloba | 1 | 2019 | 6 | 0.170 |
Why?
|
| Inflammation | 2 | 2024 | 981 | 0.170 |
Why?
|
| Gene Expression Regulation | 5 | 2017 | 1983 | 0.170 |
Why?
|
| Horses | 1 | 2019 | 35 | 0.170 |
Why?
|
| Forensic Pathology | 1 | 2019 | 3 | 0.160 |
Why?
|
| Pyramidal Cells | 3 | 2011 | 81 | 0.160 |
Why?
|
| Chronic Traumatic Encephalopathy | 1 | 2019 | 2 | 0.160 |
Why?
|
| Adaptation, Psychological | 1 | 2020 | 166 | 0.160 |
Why?
|
| Post-Concussion Syndrome | 1 | 2019 | 7 | 0.160 |
Why?
|
| Haplotypes | 1 | 2021 | 637 | 0.160 |
Why?
|
| Symbiosis | 1 | 2020 | 127 | 0.160 |
Why?
|
| Microscopy, Electron | 2 | 2013 | 511 | 0.160 |
Why?
|
| Calcium Compounds | 1 | 2018 | 2 | 0.160 |
Why?
|
| Cell Membrane Permeability | 1 | 2019 | 120 | 0.160 |
Why?
|
| Polymorphism, Genetic | 3 | 2017 | 825 | 0.160 |
Why?
|
| Ecosystem | 2 | 2020 | 353 | 0.150 |
Why?
|
| Prions | 2 | 2010 | 54 | 0.150 |
Why?
|
| Brain Concussion | 1 | 2019 | 65 | 0.150 |
Why?
|
| Cognition | 1 | 2022 | 579 | 0.150 |
Why?
|
| Dolphins | 1 | 2017 | 3 | 0.150 |
Why?
|
| Tarsiidae | 1 | 2017 | 1 | 0.140 |
Why?
|
| Sympatry | 1 | 2017 | 9 | 0.140 |
Why?
|
| Military Personnel | 1 | 2019 | 92 | 0.140 |
Why?
|
| Lemuridae | 1 | 2017 | 5 | 0.140 |
Why?
|
| Drug Stability | 1 | 2017 | 52 | 0.140 |
Why?
|
| Biomimetic Materials | 1 | 2017 | 24 | 0.140 |
Why?
|
| Female | 23 | 2019 | 46494 | 0.140 |
Why?
|
| Molecular Docking Simulation | 1 | 2017 | 49 | 0.140 |
Why?
|
| Chitin | 2 | 2007 | 10 | 0.140 |
Why?
|
| Genome, Mitochondrial | 1 | 2017 | 28 | 0.140 |
Why?
|
| Immunotherapy | 1 | 2023 | 693 | 0.140 |
Why?
|
| Metabolomics | 2 | 2014 | 76 | 0.140 |
Why?
|
| Choroid Plexus | 2 | 2013 | 14 | 0.140 |
Why?
|
| Phosphorylation | 4 | 2012 | 1130 | 0.140 |
Why?
|
| HIV Infections | 1 | 2016 | 847 | 0.140 |
Why?
|
| DNA Primers | 2 | 2008 | 543 | 0.140 |
Why?
|
| Social Justice | 1 | 2007 | 54 | 0.140 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 279 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 2017 | 175 | 0.140 |
Why?
|
| Brain Stem | 2 | 2011 | 167 | 0.140 |
Why?
|
| Seed Dispersal | 1 | 2016 | 1 | 0.130 |
Why?
|
| Holography | 1 | 2016 | 5 | 0.130 |
Why?
|
| Baltimore | 2 | 2016 | 40 | 0.130 |
Why?
|
| Chiroptera | 1 | 2017 | 54 | 0.130 |
Why?
|
| Models, Chemical | 1 | 2017 | 179 | 0.130 |
Why?
|
| Opsins | 1 | 2016 | 10 | 0.130 |
Why?
|
| Spectrum Analysis | 1 | 2016 | 119 | 0.130 |
Why?
|
| Trees | 1 | 2016 | 38 | 0.130 |
Why?
|
| Protein Multimerization | 1 | 2017 | 178 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 344 | 0.130 |
Why?
|
| Mammoths | 1 | 2015 | 1 | 0.130 |
Why?
|
| Optical Imaging | 1 | 2016 | 51 | 0.130 |
Why?
|
| Genetic Speciation | 1 | 2017 | 117 | 0.130 |
Why?
|
| Brain Injury, Chronic | 1 | 2015 | 9 | 0.130 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 2063 | 0.130 |
Why?
|
| Disease Progression | 3 | 2017 | 1466 | 0.130 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2017 | 264 | 0.130 |
Why?
|
| Chlamydophila pneumoniae | 1 | 2015 | 13 | 0.120 |
Why?
|
| Terminology as Topic | 1 | 2017 | 222 | 0.120 |
Why?
|
| Kinetics | 1 | 2017 | 1534 | 0.120 |
Why?
|
| Mast Cells | 1 | 2015 | 94 | 0.120 |
Why?
|
| Chlamydia Infections | 1 | 2015 | 31 | 0.120 |
Why?
|
| Protein Aggregates | 2 | 2024 | 24 | 0.120 |
Why?
|
| Duffy Blood-Group System | 1 | 2014 | 7 | 0.120 |
Why?
|
| Myosin Heavy Chains | 1 | 2015 | 91 | 0.120 |
Why?
|
| Uganda | 1 | 2014 | 38 | 0.120 |
Why?
|
| Binding Sites | 1 | 2017 | 1121 | 0.120 |
Why?
|
| Protein Conformation | 1 | 2017 | 895 | 0.120 |
Why?
|
| Residence Characteristics | 2 | 2016 | 203 | 0.120 |
Why?
|
| Apolipoprotein E3 | 1 | 2013 | 7 | 0.110 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 86 | 0.110 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2015 | 131 | 0.110 |
Why?
|
| Agriculture | 1 | 2014 | 39 | 0.110 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 182 | 0.110 |
Why?
|
| Time Factors | 3 | 2017 | 5350 | 0.110 |
Why?
|
| Healthcare Disparities | 1 | 2008 | 431 | 0.110 |
Why?
|
| Autopsy | 3 | 2019 | 122 | 0.110 |
Why?
|
| Protein Binding | 1 | 2017 | 1491 | 0.110 |
Why?
|
| Amyloidosis | 2 | 2012 | 130 | 0.110 |
Why?
|
| Cerebrovascular Circulation | 1 | 2015 | 231 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2014 | 288 | 0.110 |
Why?
|
| Platyrrhini | 1 | 2012 | 3 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2014 | 158 | 0.100 |
Why?
|
| DNA, Intergenic | 1 | 2012 | 28 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2011 | 1864 | 0.100 |
Why?
|
| Pseudogenes | 1 | 2012 | 34 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2016 | 575 | 0.100 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2008 | 243 | 0.100 |
Why?
|
| Systems Biology | 1 | 2012 | 44 | 0.100 |
Why?
|
| Gene Frequency | 1 | 2014 | 687 | 0.100 |
Why?
|
| Genotype | 3 | 2013 | 1853 | 0.100 |
Why?
|
| Antimicrobial Cationic Peptides | 1 | 2012 | 13 | 0.100 |
Why?
|
| Energy Metabolism | 2 | 2012 | 282 | 0.100 |
Why?
|
| RNA, Untranslated | 1 | 2012 | 65 | 0.100 |
Why?
|
| Lipofuscin | 1 | 2011 | 2 | 0.100 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2011 | 29 | 0.100 |
Why?
|
| Treatment Failure | 1 | 2012 | 278 | 0.100 |
Why?
|
| Ribosomal Protein S6 | 1 | 2011 | 5 | 0.100 |
Why?
|
| Neurobiology | 1 | 2011 | 10 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2014 | 310 | 0.100 |
Why?
|
| 1-Methyl-4-phenylpyridinium | 1 | 2011 | 12 | 0.100 |
Why?
|
| Open Reading Frames | 1 | 2011 | 121 | 0.100 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 96 | 0.100 |
Why?
|
| Nucleotides | 1 | 2011 | 98 | 0.090 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 406 | 0.090 |
Why?
|
| Adult | 11 | 2019 | 26767 | 0.090 |
Why?
|
| Retinoblastoma Protein | 1 | 2011 | 64 | 0.090 |
Why?
|
| GTP Phosphohydrolases | 1 | 2011 | 74 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 2887 | 0.090 |
Why?
|
| Dogs | 1 | 2011 | 706 | 0.090 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 2010 | 27 | 0.090 |
Why?
|
| Internet | 1 | 2013 | 323 | 0.090 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 591 | 0.090 |
Why?
|
| CD3 Complex | 1 | 2010 | 134 | 0.090 |
Why?
|
| Amino Acid Substitution | 2 | 2015 | 338 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 127 | 0.090 |
Why?
|
| Exercise | 1 | 2013 | 326 | 0.090 |
Why?
|
| Paraffin Embedding | 1 | 2010 | 78 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2010 | 101 | 0.090 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2011 | 184 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2009 | 508 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 2 | 2010 | 919 | 0.090 |
Why?
|
| Kynurenine | 1 | 2010 | 21 | 0.080 |
Why?
|
| Immunoblotting | 1 | 2010 | 272 | 0.080 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2010 | 56 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2009 | 14 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2010 | 678 | 0.080 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2009 | 4 | 0.080 |
Why?
|
| DNA Mutational Analysis | 2 | 2010 | 529 | 0.080 |
Why?
|
| S Phase | 1 | 2009 | 63 | 0.080 |
Why?
|
| Growth | 1 | 2009 | 43 | 0.080 |
Why?
|
| Superoxide Dismutase-1 | 1 | 2009 | 48 | 0.080 |
Why?
|
| Brain Neoplasms | 2 | 2006 | 783 | 0.080 |
Why?
|
| Genes, myc | 1 | 2009 | 40 | 0.080 |
Why?
|
| Neocortex | 3 | 2006 | 96 | 0.080 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2008 | 39 | 0.080 |
Why?
|
| Hypoxia, Brain | 1 | 2009 | 43 | 0.080 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 65 | 0.080 |
Why?
|
| Metal Metabolism, Inborn Errors | 1 | 2008 | 1 | 0.080 |
Why?
|
| Ceruloplasmin | 1 | 2008 | 8 | 0.080 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2009 | 144 | 0.080 |
Why?
|
| Superoxide Dismutase | 1 | 2009 | 177 | 0.070 |
Why?
|
| Starch | 1 | 2007 | 8 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 352 | 0.070 |
Why?
|
| Polysaccharides | 1 | 2007 | 91 | 0.070 |
Why?
|
| Genomic Imprinting | 1 | 2007 | 33 | 0.070 |
Why?
|
| Xanthomatosis, Cerebrotendinous | 1 | 2007 | 4 | 0.070 |
Why?
|
| Pan paniscus | 1 | 2007 | 10 | 0.070 |
Why?
|
| Antigens | 1 | 2008 | 229 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2011 | 403 | 0.070 |
Why?
|
| United States | 3 | 2019 | 7083 | 0.070 |
Why?
|
| Retinoblastoma-Like Protein p130 | 1 | 2006 | 7 | 0.070 |
Why?
|
| Gorilla gorilla | 1 | 2007 | 44 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 952 | 0.070 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 1180 | 0.070 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2007 | 102 | 0.070 |
Why?
|
| Treatment Outcome | 1 | 2019 | 8243 | 0.070 |
Why?
|
| Genome-Wide Association Study | 1 | 2014 | 1689 | 0.070 |
Why?
|
| Synapses | 1 | 2009 | 280 | 0.070 |
Why?
|
| Flow Cytometry | 2 | 2021 | 690 | 0.070 |
Why?
|
| Antibodies | 1 | 2008 | 353 | 0.070 |
Why?
|
| Family | 1 | 2008 | 325 | 0.070 |
Why?
|
| Social Isolation | 1 | 2016 | 67 | 0.070 |
Why?
|
| Geographic Information Systems | 1 | 2016 | 23 | 0.070 |
Why?
|
| Needle-Exchange Programs | 1 | 2016 | 18 | 0.070 |
Why?
|
| Health Priorities | 1 | 2016 | 22 | 0.070 |
Why?
|
| Urban Health | 1 | 2016 | 56 | 0.060 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2005 | 25 | 0.060 |
Why?
|
| Cell Cycle Proteins | 2 | 2009 | 399 | 0.060 |
Why?
|
| Glycation End Products, Advanced | 1 | 2005 | 11 | 0.060 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2005 | 88 | 0.060 |
Why?
|
| Activities of Daily Living | 1 | 2016 | 205 | 0.060 |
Why?
|
| Likelihood Functions | 1 | 2005 | 252 | 0.060 |
Why?
|
| Interviews as Topic | 1 | 2016 | 344 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2006 | 279 | 0.060 |
Why?
|
| Adolescent | 3 | 2014 | 9327 | 0.060 |
Why?
|
| Young Adult | 5 | 2019 | 6386 | 0.060 |
Why?
|
| Cerebral Amyloid Angiopathy | 1 | 2004 | 8 | 0.060 |
Why?
|
| Lysine | 1 | 2005 | 150 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2009 | 2391 | 0.060 |
Why?
|
| Urban Population | 1 | 2016 | 225 | 0.060 |
Why?
|
| Cyclin B | 1 | 2004 | 18 | 0.060 |
Why?
|
| Mice | 4 | 2011 | 11846 | 0.060 |
Why?
|
| Blood Vessels | 1 | 2004 | 94 | 0.060 |
Why?
|
| Recombination, Genetic | 1 | 2006 | 446 | 0.060 |
Why?
|
| Cyclins | 1 | 2004 | 82 | 0.060 |
Why?
|
| Molecular Structure | 1 | 2024 | 293 | 0.060 |
Why?
|
| Glioma | 1 | 2006 | 294 | 0.060 |
Why?
|
| Structure-Activity Relationship | 1 | 2024 | 414 | 0.060 |
Why?
|
| Heme Oxygenase-1 | 1 | 2003 | 20 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2016 | 871 | 0.060 |
Why?
|
| Rainforest | 1 | 2023 | 9 | 0.060 |
Why?
|
| Heme Oxygenase (Decyclizing) | 1 | 2003 | 44 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2003 | 35 | 0.050 |
Why?
|
| Electron Transport Complex IV | 1 | 2003 | 49 | 0.050 |
Why?
|
| Acclimatization | 1 | 2023 | 79 | 0.050 |
Why?
|
| Deoxyribonucleases | 1 | 2002 | 29 | 0.050 |
Why?
|
| Mitochondrial Diseases | 1 | 2002 | 12 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2023 | 276 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2002 | 93 | 0.050 |
Why?
|
| Multiple System Atrophy | 1 | 2002 | 4 | 0.050 |
Why?
|
| Deoxyguanosine | 1 | 2002 | 28 | 0.050 |
Why?
|
| Hydrocephalus | 1 | 2003 | 105 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2016 | 435 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2008 | 2360 | 0.050 |
Why?
|
| Nucleic Acids | 1 | 2002 | 32 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2016 | 457 | 0.050 |
Why?
|
| Herbivory | 1 | 2021 | 30 | 0.050 |
Why?
|
| RNA, Ribosomal | 2 | 2011 | 69 | 0.050 |
Why?
|
| Cell Survival | 2 | 2015 | 983 | 0.050 |
Why?
|
| Computer Simulation | 2 | 2016 | 1101 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2024 | 1929 | 0.040 |
Why?
|
| Amino Acids | 1 | 2021 | 246 | 0.040 |
Why?
|
| Asthma | 1 | 2008 | 983 | 0.040 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2011 | 80 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 885 | 0.040 |
Why?
|
| Biopsy | 1 | 2003 | 1184 | 0.040 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2010 | 45 | 0.040 |
Why?
|
| Chromosome Mapping | 3 | 2006 | 1074 | 0.040 |
Why?
|
| Calcium | 1 | 2024 | 1179 | 0.040 |
Why?
|
| Veterans Health | 1 | 2019 | 16 | 0.040 |
Why?
|
| Astrocytes | 2 | 2012 | 142 | 0.040 |
Why?
|
| Blotting, Western | 2 | 2011 | 793 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2583 | 0.040 |
Why?
|
| Risk Factors | 2 | 2016 | 5539 | 0.040 |
Why?
|
| Synchrotrons | 1 | 2018 | 29 | 0.040 |
Why?
|
| Social Responsibility | 1 | 2008 | 57 | 0.040 |
Why?
|
| X-Rays | 1 | 2018 | 137 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2013 | 726 | 0.040 |
Why?
|
| Callithrix | 1 | 2017 | 14 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2008 | 84 | 0.040 |
Why?
|
| Borneo | 1 | 2017 | 1 | 0.040 |
Why?
|
| Bibliometrics | 1 | 2007 | 37 | 0.040 |
Why?
|
| Policy Making | 1 | 2007 | 63 | 0.040 |
Why?
|
| Cell Line | 2 | 2012 | 2495 | 0.040 |
Why?
|
| Cytoplasm | 2 | 2009 | 285 | 0.040 |
Why?
|
| Phylogeography | 1 | 2017 | 43 | 0.030 |
Why?
|
| Climate | 1 | 2017 | 58 | 0.030 |
Why?
|
| Global Health | 1 | 2008 | 193 | 0.030 |
Why?
|
| Cell Death | 2 | 2008 | 261 | 0.030 |
Why?
|
| Gene Expression | 2 | 2014 | 1309 | 0.030 |
Why?
|
| Opossums | 1 | 2016 | 4 | 0.030 |
Why?
|
| Arctic Regions | 1 | 2015 | 10 | 0.030 |
Why?
|
| Databases, Bibliographic | 1 | 2015 | 17 | 0.030 |
Why?
|
| TRPV Cation Channels | 1 | 2015 | 16 | 0.030 |
Why?
|
| Elephants | 1 | 2015 | 17 | 0.030 |
Why?
|
| Caspase 1 | 1 | 2015 | 20 | 0.030 |
Why?
|
| Mice, Obese | 1 | 2015 | 44 | 0.030 |
Why?
|
| Environment | 1 | 2017 | 225 | 0.030 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2015 | 78 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2015 | 71 | 0.030 |
Why?
|
| Africa, Southern | 1 | 2014 | 1 | 0.030 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2015 | 141 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 1451 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 82 | 0.030 |
Why?
|
| Caspase 3 | 1 | 2015 | 162 | 0.030 |
Why?
|
| Ultraviolet Rays | 1 | 2016 | 195 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2014 | 23 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2019 | 417 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2015 | 176 | 0.030 |
Why?
|
| Genetic Drift | 1 | 2014 | 37 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2015 | 280 | 0.030 |
Why?
|
| Africa, Central | 1 | 2014 | 6 | 0.030 |
Why?
|
| Demography | 1 | 2014 | 183 | 0.030 |
Why?
|
| Africa, Western | 1 | 2014 | 11 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 433 | 0.030 |
Why?
|
| Cooking | 1 | 2014 | 56 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 740 | 0.030 |
Why?
|
| Lactic Acid | 1 | 2013 | 93 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2015 | 646 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2009 | 727 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 434 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 156 | 0.030 |
Why?
|
| Central Nervous System Diseases | 1 | 2012 | 52 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2012 | 73 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 371 | 0.020 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2011 | 29 | 0.020 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 2011 | 44 | 0.020 |
Why?
|
| Adenosine Diphosphate | 1 | 2011 | 56 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2011 | 59 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2012 | 153 | 0.020 |
Why?
|
| Microglia | 1 | 2012 | 108 | 0.020 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2011 | 22 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2019 | 2315 | 0.020 |
Why?
|
| Lewy Bodies | 1 | 2010 | 1 | 0.020 |
Why?
|
| Inclusion Bodies | 1 | 2010 | 34 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 167 | 0.020 |
Why?
|
| Dynamins | 1 | 2011 | 50 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 323 | 0.020 |
Why?
|
| Gene Silencing | 1 | 2011 | 178 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2010 | 40 | 0.020 |
Why?
|
| Culture | 1 | 2010 | 53 | 0.020 |
Why?
|
| Formaldehyde | 1 | 2010 | 52 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 316 | 0.020 |
Why?
|
| RNA Interference | 1 | 2011 | 376 | 0.020 |
Why?
|
| Child | 2 | 2014 | 7233 | 0.020 |
Why?
|
| Wound Healing | 1 | 2012 | 361 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2011 | 446 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 2009 | 2 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 909 | 0.020 |
Why?
|
| Autophagy | 1 | 2011 | 159 | 0.020 |
Why?
|
| Maze Learning | 1 | 2009 | 29 | 0.020 |
Why?
|
| Presenilins | 1 | 2008 | 6 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2012 | 433 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2012 | 451 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2008 | 26 | 0.020 |
Why?
|
| Brain Diseases, Metabolic, Inborn | 1 | 2008 | 2 | 0.020 |
Why?
|
| Nerve Growth Factor | 1 | 2008 | 18 | 0.020 |
Why?
|
| Cytokines | 1 | 2012 | 811 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2008 | 87 | 0.020 |
Why?
|
| Heparitin Sulfate | 1 | 2007 | 27 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2014 | 2498 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3250 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 423 | 0.020 |
Why?
|
| Sp Transcription Factors | 1 | 2007 | 1 | 0.020 |
Why?
|
| Biological Transport, Active | 1 | 2007 | 102 | 0.020 |
Why?
|
| Extraembryonic Membranes | 1 | 2007 | 8 | 0.020 |
Why?
|
| Infant | 1 | 2014 | 3187 | 0.020 |
Why?
|
| Synteny | 1 | 2007 | 28 | 0.020 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 1 | 2007 | 7 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 16 | 0.020 |
Why?
|
| Euchromatin | 1 | 2006 | 6 | 0.020 |
Why?
|
| Achilles Tendon | 1 | 2007 | 15 | 0.020 |
Why?
|
| Gene Duplication | 1 | 2008 | 129 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2006 | 63 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2014 | 3765 | 0.020 |
Why?
|
| Cognition Disorders | 1 | 2009 | 234 | 0.020 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2007 | 60 | 0.020 |
Why?
|
| Hormones | 1 | 2007 | 139 | 0.020 |
Why?
|
| Vitamin E | 1 | 2006 | 32 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2006 | 223 | 0.020 |
Why?
|
| CpG Islands | 1 | 2007 | 158 | 0.020 |
Why?
|
| Huntingtin Protein | 1 | 2006 | 13 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2010 | 541 | 0.020 |
Why?
|
| Huntington Disease | 1 | 2006 | 39 | 0.020 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2006 | 72 | 0.020 |
Why?
|
| Neuroglia | 1 | 2006 | 105 | 0.020 |
Why?
|
| Nitric Oxide Synthase | 1 | 2006 | 126 | 0.020 |
Why?
|
| Syndrome | 1 | 2007 | 450 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2007 | 296 | 0.020 |
Why?
|
| Autistic Disorder | 1 | 2007 | 150 | 0.020 |
Why?
|
| Lipid Metabolism | 1 | 2007 | 201 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2012 | 1669 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2008 | 244 | 0.020 |
Why?
|
| Risk Reduction Behavior | 1 | 2006 | 97 | 0.020 |
Why?
|
| Vaccination | 1 | 2008 | 278 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 2007 | 234 | 0.020 |
Why?
|
| Benzenesulfonates | 1 | 2005 | 50 | 0.020 |
Why?
|
| Apoptosis | 1 | 2012 | 1717 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2006 | 477 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 1576 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 1255 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 4048 | 0.010 |
Why?
|
| Histones | 1 | 2007 | 333 | 0.010 |
Why?
|
| Research Design | 1 | 2008 | 591 | 0.010 |
Why?
|
| Cyclin B1 | 1 | 2004 | 18 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2004 | 40 | 0.010 |
Why?
|
| G2 Phase | 1 | 2004 | 33 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2008 | 377 | 0.010 |
Why?
|
| Cytosol | 1 | 2004 | 193 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2008 | 614 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 79 | 0.010 |
Why?
|
| Software | 1 | 2008 | 669 | 0.010 |
Why?
|
| Mitosis | 1 | 2004 | 152 | 0.010 |
Why?
|
| Models, Biological | 1 | 2010 | 1765 | 0.010 |
Why?
|
| Cytochromes | 1 | 2002 | 57 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 662 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2007 | 663 | 0.010 |
Why?
|
| Mutation | 2 | 2005 | 4164 | 0.010 |
Why?
|
| DNA Methylation | 1 | 2007 | 664 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2008 | 1394 | 0.010 |
Why?
|
| Proteins | 1 | 2007 | 786 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2002 | 374 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2007 | 2025 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 2765 | 0.010 |
Why?
|
| Algorithms | 1 | 2006 | 1904 | 0.010 |
Why?
|